Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

189

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C02AC05	CYNT	B	Moxonidine - 0.2mg	0.2mg	Tablet, film coated	937,444 L.L
A03AB02	GLYCOPYRROLATE	B	Glycopyronium Bromide - 0.2mg/ml	0.2mg/ml	Injectable solution	7,238,185 L.L
D10AD03	DIFADERM	G	Adapalene - 0.3%	0.3%	Gel	952,208 L.L
S01AA12	TOBRACIN	G	Tobramycin - 0.3%	0.3%	Drops	322,522 L.L
S01AA12	TOBRASTILL	G	Tobramycin - 0.3%	0.3%	Drops solution	258,018 L.L
S01AA12	TOBRIN	G	Tobramycin - 0.3%	0.3%	Drops	169,324 L.L
S01AA12	TOBRACIN	G	Tobramycin - 0.3%	0.3%	Ointment	280,863 L.L
S01AA23	NETTACIN	B	Netilmicin - 0.3%	0.3%	Drops solution	681,328 L.L
S01AA23	NETTACIN	B	Netilmicin - 0.3%	0.3%	Ointment	593,978 L.L
S01AE01	OFLOX	B	Ofloxacin - 3mg/ml	0.3%	Drops solution	366,869 L.L
S01AE01	OFLOX	B	Ofloxacin - 0.3%	0.3%	Drops solution	366,869 L.L
R06AD08	TOPLEXIL	B	Oxomemazine HCl - 0.33mg/ml	0.33mg/ml	Syrup	615,480 L.L
R06AD08	OXOMIL	G	Oxomemazine HCl - 0.33mg/ml	0.33mg/ml	Syrup, sugar free	511,940 L.L
R06AD08	OXOMEMAZINE ARROW	G	Oxomemazine HCl - 0.33mg/ml	0.33mg/ml	Syrup	431,373 L.L
R06AD08	OXOMEMAZINE ARROW	G	Oxomemazine HCl - 0.33mg/ml	0.33mg/ml	Solution, sugar free	431,373 L.L
N04BC05	SIFROL ER	B	Pramipexole (dihydrochloride monohydrate) - 0.375mg	0.375mg	Tablet, extended release	473,033 L.L
N02BA01	ASPIRINE	B	Acetylsalicylic acid - 300mg	0.3g	Tablet	80,631 L.L
C02AC05	CYNT	B	Moxonidine - 0.3mg	0.3mg	Tablet, film coated	1,266,372 L.L
H01CB05	SIGNIFOR	B	Pasireotide (diaspartate) - 0.3mg/ml	0.3mg/ml	Injectable solution	175,400,801 L.L
S01HA02	ANESTOCIL	B	Oxybuprocaine HCl (Benoxinate HCl) - 0.4%	0.4%	Drops solution	442,124 L.L
B05XA03	0.45% SODIUM CHLORIDE INJECTION USP	G	Sodium chloride - 0.45%	0.45%	Injectable solution	160,885 L.L
B05XA03	0.45% SODIUM CHLORIDE INJECTION USP	G	Sodium chloride - 0.45%	0.45%	Injectable solution	176,974 L.L
B05XA03	0.45% SODIUM CHLORIDE INJECTION USP	G	Sodium chloride - 0.45%	0.45%	Injectable solution	137,902 L.L
B05XA03	0.45% SODIUM CHLORIDE INJECTION USP	G	Sodium chloride - 0.45%	0.45%	Injectable solution	155,139 L.L
B05XA03	HYPOTONIC SALINE	G	Sodium chloride - 0.45%	0.45%	Injectable solution	149,393 L.L
B05XA03	HYPOTONIC SALINE	G	Sodium chloride - 0.45%	0.45%	Injectable solution	163,184 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.45%	0.45%	Injectable solution	133,856 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.45%	0.45%	Injectable solution	149,393 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.45%	0.45%	Injectable solution	163,184 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.45%	0.45%	Injectable solution	176,974 L.L

...

189